The article describes complex of organizational legal aspects of oncological screening for gynecological and urological diseases. These types of screening can be considered as preventive measure not only preventing development of malignant tumors of genitourinary system, but preserving male and female reproductive health, since protection of reproductive health is also preservation of public health of population.